查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1827306

药品包装市场按材料、产品类型、包装等级、药品类型、剂型、最终用户和分销划分 - 全球预测 2025-2032

Pharmaceutical Packaging Market by Material, Product Type, Level of Packaging, Drug Type, Form, End User, Distribution - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，医药包装市场规模将成长至 3,625.4 亿美元，复合年增长率为 9.84%。

主要市场统计数据
基准年2024年 1709.8亿美元
预计2025年 1871.8亿美元
预测年份：2032年 3625.4亿美元
复合年增长率（%） 9.84%

药品包装如何转变为一种策略性的、多学科的功能，以推动整个复杂供应链中的产品完整性、法规遵循和以患者为中心的设计

随着製造商面临多重压力：监管的复杂性、永续性的迫切需求以及快速的治疗方法创新，医药包装领域正进入一个战略重要性日益提升的时期。包装不再只是被动的容纳功能，而是积极地促进产品完整性、病人安全、供应链韧性和品牌信任。生物製药、组合药物和精准给药疗法的发展，对材料、无菌处理和设备整合提出了更高的技术要求，而以患者为中心的设计考量和依从性支援功能，正在将包装决策推向产品开发的上游。

同时，外部力量正在重塑采购和供应风险状况。监管机构正在实施更严格的序列化和追踪要求，环境政策制定者正在加速推动可回收性和减少塑胶使用的政策，贸易动态也促使采购团队重新评估采购区域。这些发展迫使包装领导者更快、更有系统地整合跨职能投入，例如品质保证、法规事务、供应链和研发。

因此，包装策略需要多维度的方法，以平衡材料科学、工艺能力、法规遵循和最终用户体验。产业相关人员迫切需要创建适应性强的包装平台，以适应不断变化的治疗方式和监管标准，同时优化成本、永续性和供应连续性。本执行摘要概述了最重要的趋势和实用建议，以帮助决策者应对这一复杂的环境。

重塑医药包装技术、永续性、供应链弹性和法规遵循的七个关键产业变化

该行业正在经历一波转型浪潮，重新定义了包装相关人员的角色、职责和价值提案。序列化、数位印刷和整合感测器等技术进步，正在将包装转变为一个数据丰富的介面，支援可追溯性、温度监控和患者用药依从性。同时，永续性不再是边缘话题，而已成为产品管理的核心。品牌和製造商正在重新设计主要和次要组件，以最大限度地降低碳强度并提高可回收性。

在营运方面，自动化和模组化生产线正在加速无菌生产环境中的产量并降低污染风险。随着人们越来越偏好使用一次性技术和无菌处理平台来支持生技药品和其他敏感产品，这一趋势也得到了进一步的强化。在采购方面，製造商越来越注重供应商的协作和透明度，并寻求下游对材料来源和加工足迹的可视性。

监管协调工作以及更严格的包装和标籤要求迫使企业透过设计来建立合规性。同时，组合产品和预填充给药系统的兴起正在推动器械工程与传统包装功能的整合。总而言之，这些转变需要一种更具迭代性、多学科的包装策略方法，在这种方法中，持续创新和强大的风险管理与清晰的患者疗效和环境倡议并存。

评估近期关税变化对全球医药包装采购、供应链配置、合规负担和材料替代动态的连锁影响

主要进口国实施的累积关税措施，包括近期贸易政策週期中宣布的关税调整，正在对采购决策、供应商多元化以及封装组件总到岸成本的考量产生显着影响。关税提高了进口材料和成品封装组件的实际成本，促使製造商和加工商重新评估其全球布局和短期筹资策略。为此，许多公司正在加快在地化进程，优先从免税和低风险地区采购，并增加关键元件的安全库存，以平滑短期波动。

除了直接的成本影响外，关税环境也带来了行政管理的复杂性，影响了前置作业时间和营运成本。特种零件，尤其是镀膜玻璃、阻隔膜和精密瓶盖等零件，可能会因关税分类争议、复合材料关税状态变化以及不断变化的文件要求而面临下游中断。这些营运影响通常表现为替代供应商的采用延迟、资格认证活动的延迟以及供应链合规性审核的增加。

从战略上讲，关税也促使人们重新评估材料替代和设计优化。包装工程师正在探索替代方案，以减少对高投入负荷的依赖，同时又不损害屏障保护、萃取物和可浸出特性以及无菌保证。同时，采购团队正在协商包含双重采购条款和灵活数量承诺的长期合同，以应对进一步的贸易波动。因此，关税主导的成本压力和行政负担的综合影响正在加速供应链重组，迫使产业相关人员采用更具活力的采购模式，投资于区域製造业的韧性，并深化其供应商生态系统内的合作。

目标細項分析揭示了材料科学、产品形式、包装水平、剂型和分销管道如何决定技术要求和商业策略

清楚了解市场区隔对于确保产品开发和商业策略与客户需求和监管约束一致至关重要。包装评估涵盖铝箔、玻璃、纸张以及塑胶和聚合物，其中分析的塑胶包括聚乙烯 (PE)、聚对苯二甲酸乙二醇酯 (PET)、聚丙烯 (PP)、聚苯乙烯 (PS) 和聚氯乙烯(PVC)。这些材料之间的差异性决定了其阻隔性能、灭菌製程相容性、可回收性以及肠外和口服剂型的监管可接受性。

产品类型进一步区分了需求和价值提案。包装形式多种多样，从安瓿瓶和泡壳包装到瓶子、瓶盖和封口、药筒、标籤和配件、包装袋、预填充吸入器、预填充式注射器和管瓶，每种包装在容器完整性、剂量准确性和设备集成度方面都有特定的限制。包装等级也是决定性因素：一级包装在生物相容性和无菌性方面要求最高标准，二级包装力求在保护性和配送效率之间取得平衡，三级包装则强调码垛、运输稳健性和负载稳定性。

药品类型和剂型决定了技术规范和认证途径。这些包括非无菌和无菌药物，以及液体、半固态和固态剂型，每种剂型都需要不同的材料和製程。最终用户细分将受託製造厂商与製药商区分开来，后者进一步细分为品牌製造商和非专利製造商。直销、分销商/批发商和线上平台等分销管道对标籤、保质期控制和序列追踪提出了额外的限制。整合这些细分维度，使公司能够更精准地定位产品系列，投资合适的工具和品质体系，并设计出能够反映整个价值链中买方行为的上市方案。

区域营运比较和策略影响，重点介绍美洲、欧洲、中东和非洲以及亚太地区将如何影响包装投资、采购和监管协调

区域动态正在以不同的方式塑造製造商的策略和投资重点。在美洲，先进的生技药品产品线和成熟的法规结构正在推动对可靠的初级包装和先进设备整合的需求，而成熟的契约製造基地则持续影响生产力计画和近岸外包趋势。相较之下，欧洲、中东和非洲则拥有严格的监管环境、雄心勃勃的循环经济计画和多样化的供应生态系统，迫使企业在多个司法管辖区内协调合规性和永续性。

亚太地区的特点是产能快速扩张、管理体制不断演变以及强大的国内製造能力。该地区是材料生产和加工能力的中心，在提供规模优势的同时，也使全球供应链面临集中的地缘政治和物流风险。製造商正在采用混合筹资策略，有意分散整个地区的风险，将大批量零件的区域製造中心与专门的利基技术零件供应商结合。

这些地理动态影响製造资产的资本配置决策，包括优先考虑区域品质和监管投资，以及设计分销网络以最大程度地降低运输复杂性和关税风险。将区域业务模式与产品系列和监管策略相结合的公司，将能够快速回应本地市场需求，同时保持全球品质和永续性绩效的一致性。

竞争格局洞察：策略伙伴关係、重点投资和技术专业化如何重新定义包装供应商和转换器的能力和服务模式

医药包装领域正日益由策略伙伴关係、定向收购和技术许可所定义，这些措施加速了企业的能力建构。领先的材料供应商和加工商正在投资阻隔技术、可回收树脂配方和先进的涂层系统，以满足性能预期和监管审查。同时，合约包装商和设备合作伙伴正在透过整合服务模式脱颖而出，将灌装、检验、序列化和二次组装整合到一个资格确认时间。

创新通常由跨产业合作驱动，医疗设备工程、食品包装和消费品领域的洞见转化为更强大、更人性化的解决方案。拥有成熟全球业务的公司正在利用其规模优势投资数位化，部署追踪平台和预测维修系统，以延长运转率并确保合规性。利基市场参与者则专注于需要深厚工程专业知识和严格製程控制的高价值技术领域，例如用于注射剂的特殊玻璃、复杂的封盖以及儿科专用设计。

在此背景下，製药商与包装供应商之间的伙伴关係正变得更加战略化和长期化，强调共同开发、共同风险分担以及在产品开发生命週期的早期阶段融入。成功的企业将是那些能够整合材料科学、自动化和数据主导的品质保证，从而实现规模化绩效和合规性的企业。

为高阶主管领导层提供可操作的跨职能优先事项，以建立弹性采购、永续材料策略和灵活的包装运营，从而降低贸易和监管风险

医药包装领导者必须采取果断的协作行动，以确保韧性、合规性和永续成长。首先，采购和工程团队应共同实施材料多元化策略，减少对单一来源供应商和高关税地区的依赖，同时保持技术效能和法规合规性。同时，组织应加快可回收性设计工作，优先选择符合循环经济目标且不影响阻隔性能或无菌保证的材料。

营运投资应重点关注模组化自动化、一次性製程设备以及可快速重新配置以适应不同规格的软质包装线。这种方法可以缩短资格确认时间，并降低新产品推出的资本强度。企业还应在整个包装生命週期中融入数位可追溯性解决方案，以支援序列化、低温运输和即时品质干预。共用共同开发契约和共享绩效指标来加强供应商协作，可以提高材料来源和生产能力的可视性。

最后，企业应进行情境规划，将贸易政策变化、原材料波动和监管加强等因素纳入考量。对供应商网路进行压力测试，并制定应急计划，例如预先审核合格的替代供应商和库存缓衝，可以帮助领导者在发生供应中断时保持供应的连续性。投资劳动力，尤其是品质工程和自动化维护，可以确保流程改善转化为持续的营运绩效和合规性。

结合初步访谈、供应链映射和文件分析的方法研究框架，检验包装趋势、风险点和实际实施路径

支撑本分析的调查方法结合了结构化的一手资料研究、全面的二手资料审查和方法论三角检验，以确保研究的稳健性和实践相关性。一手资料研究包括对包装工程师、采购主管、法规事务专家和製造外包主管的半结构化访谈，并在可能的情况下辅以现场考察和流程巡查。这些工作提供了对合规时间表、材料性能问题和近期投资重点的直接洞察。

次要工作包括整合公开的监管指南、专利申请、标准文件、产业白皮书和供应商技术资料表，以绘製材料特性、灭菌相容性和可回收性概况。供应链映射技术用于追踪从树脂和玻璃生产、加工和组装到成品分销的物料流。此映射突出了集中风险、物流限制和潜在的单点故障。

分析三角检验法检验了定性和资讯来源资讯来源的主题，案例研究分析为选定的包装创新提供了切实可行的实施途径。本调查方法的限制包括供应商特定绩效资料的固有差异性，以及贸易政策的动态性（可能快速改变行政要求）。为了缓解这些限制，本研究强调适用于不同市场情境的原则和决策框架，而非依赖波动的数值预测。

综合审查结果显示，包装产业领导者迫切需要整合永续性、数位可追溯性和弹性采购，以确保产品完整性和市场进入。

日益增加的法规、永续性要求和治疗方法创新的整合，已将医药包装从交易型采购类别提升为一项战略能力，对产品安全、市场进入和品牌价值产生重大影响。那些拥抱跨职能协作、投资于适应性强的生产架构、并优先考虑符合技术和环境要求的材料和设计的企业，最有能力提供弹性供应和差异化产品。

关税驱动的采购变化和特定地区的监管要求凸显了多元化供应商生态系统和健全应急计画的必要性。同时，数位化和整合可追溯性为改善品质监管、降低召回风险和提升病患服务提供了切实可行的途径。最终，包装领导者必须在短期业务永续营运与永续性和创新的长期投资之间取得平衡，以确保其包装选择能够保护产品完整性并增强组织的韧性。

本执行摘要中的建议为决策者提供了一份实用的路线图，以使包装策略与更广泛的企业蓝图保持一致，减少供应链和贸易波动的影响，并加速采用可增强法规遵从性和患者治疗效果的技术。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 增加可客製化的多剂量管瓶包装，并配备防篡改密封，用于个人化肿瘤治疗
  • 数位印刷技术在药品泡壳包装可变数据印刷的应用日益广泛
  • 可生物降解的聚合物涂层可提高药物稳定性并减少对环境的影响
  • 整合支援物联网的智慧标籤，实现即时温度监控和篡改检测
  • 具有防潮功能的可剥离盖膜的进展
  • 引入机器视觉检测技术，用于高速泡壳包装生产线的早期缺陷检测
  • 整合RFID智慧标籤，实现低温运输物流即时温度监控
  • 医药供应链对永续和可生物降解包装材料的需求不断增长
  • 扩大低温运输包装创新，支持温度敏感疫苗的全球分销
  • 加强序列化与追踪技术的整合，打击假药

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

第八章 药品包装市场（依材料）

  • 铝箔
  • 玻璃
  • 纸
  • 塑胶和聚合物
    • 聚乙烯（PE）
    • 聚对苯二甲酸乙二醇酯（PET）
    • 聚丙烯（PP）
    • 聚苯乙烯（PS）
    • 聚氯乙烯（PVC）

第九章 药品包装市场（依产品类型）

  • 安瓿
  • 泡壳包装
  • 瓶子
  • 瓶盖和封盖
  • 墨水匣
  • 标籤和配件
  • 小袋
  • 预填充吸入器
  • 预填充式注射器
  • 管瓶

第 10 章 药品包装市场（依包装等级）

  • 基本的
  • 次要的
  • 第三纪

第十一章 药品包装市场（依药品类型）

  • 非无菌药品
  • 无菌药品

第十二章 药品包装市场（按类型）

  • 液体
  • 半固体
  • 固体的

第十三章 药品包装市场（依最终用户）

  • 契约製造组织
  • 製药製造业
    • 品牌製造商
    • 学名药製造商

第十四章 药品包装市场分布

  • 直销
  • 分销商和批发商
  • 在线的

第十五章 医药包装市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十六章 药品包装市场（依类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十七章 各国药品包装市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十八章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • 3M Company
    • Adelphi Group Ltd
    • Alpla Werke Alwin Lehner GmbH & Co KG
    • Amcor PLC
    • AptarGroup, Inc.
    • Becton, Dickinson and Company
    • Berry Global, Inc.
    • Catalent, Inc.
    • CCL Industries Inc.
    • Comar
    • Constantia Flexibles GmbH
    • Drug Plastics & Glass Co., Inc
    • EPL Limited
    • Gaplast GmbH
    • Gerresheimer AG
    • Huhtamaki Oyj
    • KP Holding GmbH & Co.
    • Lonza Group AG
    • McKesson Corporation
    • Mondi PLC
    • Nipro Corporation
    • Nolato AB
    • Oliver Healthcare Packaging Company
    • Origin Pharma Packaging
    • PGP Glass Private Limited
    • Schott AG
    • Sealed Air Corporation
    • SGD SA
    • Sharp Services, LLC
    • SiO2 Medical Products Inc.
    • Stevanato Group
    • TEKNI-PLEX, INC.
    • Thermo Fisher Scientific Inc.
    • URSATEC GmbH
    • Vetter Pharma-Fertigung GmbH & Co. KG
    • WL Gore & Associates Inc.
    • West Pharmaceutical Services, Inc.
    • Westrock Company by Smurfit Kappa Group
Product Code: MRR-434CCDA04670

The Pharmaceutical Packaging Market is projected to grow by USD 362.54 billion at a CAGR of 9.84% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 170.98 billion
Estimated Year [2025] USD 187.18 billion
Forecast Year [2032] USD 362.54 billion
CAGR (%) 9.84%

How pharmaceutical packaging has transformed into a strategic, multidisciplinary function driving product integrity, regulatory compliance, and patient-centric design across complex supply chains

The pharmaceutical packaging landscape has entered a period of heightened strategic importance as manufacturers confront simultaneous pressures from regulatory complexity, sustainability imperatives, and rapid therapeutic innovation. Packaging is no longer a passive containment function; it is an active enabler of product integrity, patient safety, supply chain resilience, and brand trust. Advances in biologics, combination products, and precision-dosed therapies have amplified the technical requirements for materials, aseptic processing, and device integration, while patient-centric design considerations and adherence-support features have moved packaging decisions upstream into product development.

At the same time, external forces are reshaping procurement and supply risk profiles. Regulatory authorities are implementing stricter serialization and track-and-trace requirements, environmental policymakers are accelerating mandates on recyclability and plastic reduction, and trade dynamics are prompting procurement teams to re-evaluate sourcing geographies. These dynamics require packaging leaders to integrate cross-functional inputs from quality assurance, regulatory affairs, supply chain, and R&D earlier and more systematically.

Consequently, packaging strategy now demands a multidimensional approach that balances material science, process capability, regulatory compliance, and end-user experience. The imperative for industry participants is to build adaptable packaging platforms that can accommodate evolving therapeutic modalities and regulatory standards while optimizing for cost, sustainability, and supply continuity. This executive summary consolidates the most consequential trends and practical recommendations to help decision-makers navigate this complex environment.

The seven pivotal industry shifts reshaping pharmaceutical packaging technology, sustainability, supply chain resilience, and regulatory compliance in the near term

The industry is experiencing a wave of transformative shifts that are redefining the roles, responsibilities, and value propositions of packaging stakeholders. Technological advances such as serialization, digital printing, and integrated sensors are converting packaging into a data-rich interface that supports traceability, temperature monitoring, and patient adherence. Concurrently, sustainability is no longer a peripheral conversation; it is central to product stewardship. Brands and manufacturers are reengineering primary and secondary components to minimize carbon intensity and improve recyclability, while also preparing for extended producer responsibility mandates.

Operationally, automation and modular production lines are accelerating throughput and reducing contamination risk in sterile manufacturing environments. This trend is reinforced by a growing preference for single-use technologies and aseptic processing platforms to support biologics and other sensitive products. In procurement, there is a pronounced shift toward supplier collaboration and transparency, with manufacturers seeking downstream visibility into material origins and processing footprints.

Regulatory harmonization efforts and more stringent packaging and labeling requirements are prompting companies to embed compliance by design. At the same time, the rise of combination products and pre-filled delivery systems is increasing integration between device engineering and traditional packaging functions. Taken together, these shifts demand a more iterative, cross-disciplinary approach to packaging strategy, where continuous innovation and robust risk management coexist with a clear line of sight to patient outcomes and environmental commitments.

Assessing the cascading effects of recent tariff changes on global pharmaceutical packaging procurement, supply chain configuration, compliance burden, and material substitution dynamics

Cumulative tariff actions implemented by major importing economies, including tariff adjustments announced in recent trade policy cycles, have exerted a measurable influence on sourcing decisions, supplier diversification, and total landed cost considerations for packaging components. Tariffs raise the effective cost of imported materials and finished packaging assemblies, prompting manufacturers and converters to review their global footprints and near-term procurement strategies. In response, many firms have accelerated localization efforts, prioritized sourcing from tariff-exempt or lower-risk jurisdictions, and increased safety stock for critical components to smooth short-term volatility.

Beyond direct cost effects, tariff environments introduce administrative complexity that affects lead times and working capital. Customs classification disputes, changes in duty treatment for composite materials, and evolving documentation requirements can create downstream disruptions, particularly for specialized components such as coated glass, barrier films, and precision closures. These operational impacts often manifest as slower onboarding of alternative suppliers, delayed qualification activities, and increased auditing of supply-chain compliance.

Strategically, tariffs have also prompted a re-evaluation of material substitution and design optimization. Packaging engineers are exploring alternatives that reduce dependency on high-duty inputs without compromising barrier protection, extractables and leachables profiles, or sterility assurance. Simultaneously, procurement teams are negotiating longer-term contracts with dual-sourcing clauses and flexible volume commitments to hedge against further trade volatility. As a result, the combined effect of tariff-driven cost pressure and administrative burden is accelerating supply chain reconfiguration, compelling industry players to adopt more dynamic sourcing models, invest in regional manufacturing resilience, and deepen collaboration across supplier ecosystems.

Targeted segmentation analysis revealing how material science, product formats, packaging levels, drug modalities, and distribution channels determine technical requirements and commercial strategy

A clear understanding of market segmentation is essential to align product development and commercial strategy with customer needs and regulatory constraints. Material selection plays a foundational role: packaging is evaluated across Aluminum Foil, Glass, Paper, and Plastics & Polymers, and within plastics the analysis delves into polyethylene (PE), polyethylene terephthalate (PET), polypropylene (PP), polystyrene (PS), and polyvinyl chloride (PVC). These material distinctions drive decisions about barrier performance, compatibility with sterilization processes, recyclability, and regulatory acceptability for parenteral and oral dosage forms.

Product typology further differentiates requirements and value propositions. Packaging formats range from ampoules and blister packs to bottles, caps and closures, cartridges, labels and accessories, pouches, pre-filled inhalers, pre-filled syringes, and vials, each carrying specific constraints in terms of containment integrity, dose accuracy, and device integration. Packaging level is another decisive axis: primary containers demand the highest standards for biocompatibility and sterility, secondary packaging must balance protection with distribution efficiency, and tertiary packaging focuses on palletization, transport robustness, and load stability.

Drug modality and dosage form shape technical specifications and qualification pathways. The landscape includes both non-sterile and sterile drugs, and dosage forms such as liquid, semi-solid, and solid presentations, which impose different material and processing requirements. End-user segmentation distinguishes contract manufacturing organizations from pharmaceutical manufacturers, with the latter category further split into branded and generic manufacturers, each with distinct innovation cycles and margin pressures. Distribution channels-direct sales, distributors and wholesalers, and online platforms-introduce additional constraints on labeling, shelf life management, and serialized tracking. By synthesizing these segmentation dimensions, companies can more precisely target product portfolios, invest in the right tooling and quality systems, and design go-to-market approaches that reflect buyer behavior across the value chain.

Regional operational contrasts and strategic implications highlighting how the Americas, Europe Middle East & Africa, and Asia-Pacific influence packaging investment, sourcing, and regulatory alignment

Regional dynamics are shaping manufacturer strategies and investment priorities in distinct ways. In the Americas, advanced biologics pipelines and mature regulatory frameworks are driving demand for high-integrity primary packaging and sophisticated device integrations, while an established contract manufacturing base continues to influence capacity planning and nearshoring trends. In contrast, the Europe, Middle East & Africa landscape presents a blend of stringent regulatory expectations, ambitious circular economy commitments, and diverse supply ecosystems, pushing firms to harmonize compliance and sustainability across multiple jurisdictions.

Asia-Pacific is characterized by a complex interplay of rapid capacity expansion, evolving regulatory regimes, and strong domestic manufacturing capabilities. This region is a focal point for materials production and converter capacity, offering scale advantages but also exposing global supply chains to concentrated geopolitical and logistical risks. Cross-regionally, manufacturers are adopting hybrid sourcing strategies that intentionally distribute risk, pairing regional manufacturing hubs for high-volume components with specialized suppliers for niche technical elements.

These geographic dynamics influence decisions about capital allocation for manufacturing assets, the prioritization of regional quality and regulatory investments, and the design of distribution networks that minimize transit complexity and tariff exposure. Companies that align regional operational models with product portfolios and regulatory strategies position themselves to respond quickly to local market needs while maintaining global consistency in quality and sustainability performance.

Competitive landscape insights showing how strategic partnerships, targeted investments, and technical specialization are redefining capability and service models among packaging suppliers and converters

Competitive dynamics in pharmaceutical packaging are increasingly defined by strategic partnerships, targeted acquisitions, and technology licensing that accelerate capability building. Leading material suppliers and converters are investing in barrier technologies, recyclable resin formulations, and advanced coating systems to meet performance expectations and regulatory scrutiny. At the same time, contract packagers and device partners are differentiating through integrated service models that combine filling, inspection, serialization, and secondary assembly in a single validated flow to reduce qualification timelines.

Innovation is frequently driven by cross-industry collaboration, where insights from medical device engineering, food packaging, and consumer goods inform more robust and user-friendly solutions. Companies with established global footprints are leveraging scale to invest in digitization, deploying track-and-trace platforms and predictive maintenance systems to enhance uptime and ensure regulatory readiness. Niche players are focusing on high-value technical segments such as specialty glass for injectables, complex closures, and child-resistant designs that require deep engineering expertise and tight process control.

Given these dynamics, partnerships between pharmaceutical manufacturers and packaging suppliers are becoming more strategic and long-term, emphasizing co-development, joint risk-sharing, and early integration into product development lifecycles. The firms that succeed will be those that can integrate materials science, automation, and data-driven quality assurance to deliver both performance and compliance at scale.

Actionable, cross-functional priorities for executives to build resilient procurement, sustainable materials strategies, and flexible packaging operations that mitigate trade and regulatory risks

Leaders in pharmaceutical packaging must take decisive and coordinated actions to ensure resilience, compliance, and sustainable growth. First, procurement and engineering teams should jointly implement a material diversification strategy that reduces dependency on single-source suppliers and high-tariff geographies while preserving technical performance and regulatory suitability. Parallel to this, organizations should accelerate design-for-recyclability initiatives and prioritize materials that align with circular economy objectives without compromising barrier properties or sterility assurance.

Operational investments should emphasize modular automation, single-use process equipment, and flexible packaging lines that can be rapidly retooled for different formats. This approach shortens qualification timelines and reduces capital intensity for new product introductions. Companies should also embed digital traceability solutions across the packaging lifecycle to support serialization, cold-chain monitoring, and real-time quality interventions. Strengthening supplier collaboration through joint development agreements and shared performance metrics will improve visibility into material provenance and production capacity.

Finally, firms should undertake scenario planning that considers trade-policy shifts, raw material volatility, and regulatory tightening. By stress-testing supplier networks and establishing contingency plans-such as pre-qualified alternate suppliers and inventory buffers-leaders can maintain continuity of supply when disruptions occur. Investing in workforce capability, particularly in quality engineering and automation maintenance, will ensure that process improvements translate into sustained operational performance and regulatory compliance.

Methodical research framework combining primary interviews, supply-chain mapping, and documentary analysis to validate packaging trends, risk points, and practical implementation pathways

The research approach underpinning this analysis combined structured primary research, comprehensive secondary review, and methodological triangulation to ensure robustness and practical relevance. Primary inputs included semi-structured interviews with packaging engineers, heads of procurement, regulatory affairs specialists, and contract manufacturing executives, supplemented by site visits and process walkdowns where feasible. These engagements provided direct insight into qualification timelines, material performance concerns, and near-term investment priorities.

Secondary work incorporated publicly available regulatory guidance, patent filings, standards documentation, industry white papers, and supplier technical datasheets to map material properties, sterilization compatibility, and recyclability profiles. Supply-chain mapping techniques were used to trace material flows from resin and glass production through converting and assembly to finished-product distribution. This mapping highlighted concentration risk, logistics constraints, and potential single points of failure.

Analytical triangulation validated themes across qualitative and documentary sources, and case study analyses illustrated practical implementation paths for select packaging innovations. Limitations of the methodology include the inherent variability of proprietary supplier performance data and the dynamic nature of trade policy, which can change administrative requirements rapidly. To mitigate these constraints, the study emphasized principles and decision frameworks that remain applicable across different market scenarios rather than relying on volatile numerical projections.

Concluding synthesis highlighting the urgency for packaging leaders to integrate sustainability, digital traceability, and resilient sourcing to secure product integrity and market access

The convergence of regulatory tightening, sustainability mandates, and therapeutic innovation has elevated pharmaceutical packaging from a transactional procurement category to a strategic capability that materially affects product safety, market access, and brand value. Organizations that embrace cross-functional collaboration, invest in adaptable production architectures, and prioritize materials and designs that meet both technical and environmental requirements will be best positioned to deliver resilient supply and differentiated products.

Tariff-induced sourcing shifts and region-specific regulatory expectations underscore the need for diversified supplier ecosystems and robust contingency planning. At the same time, digitalization and integrated traceability offer tangible pathways to improve quality oversight, reduce recall risk, and enhance patient-facing services. Ultimately, packaging leaders must balance near-term operational continuity with longer-term investments in sustainability and innovation, ensuring that packaging choices both protect product integrity and advance organizational resilience.

The recommendations in this executive summary provide a practical roadmap for decision-makers to align packaging strategy with broader corporate objectives, reduce exposure to supply-chain and trade fluctuations, and accelerate the adoption of technologies that enhance both regulatory compliance and patient outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Increase in customizable multi dose vial packaging with tamper evident seals for personalized oncology treatments
  • 5.2. Growing use of digital printing techniques for variable data on pharmaceutical blister packs
  • 5.3. Adoption of biodegradable polymer coatings to extend drug stability and reduce environmental footprint
  • 5.4. Integration of IoT-enabled smart labels for real-time temperature monitoring and tamper detection
  • 5.5. Advancement of peelable lidding films with moisture barrier layers
  • 5.6. Implementation of machine vision inspection technologies for early defect detection in high speed blister packaging lines
  • 5.7. Integration of RFID-enabled smart labels for real time temperature monitoring in cold chain logistics
  • 5.8. Rising demand for sustainable and biodegradable packaging materials in pharmaceutical supply chains
  • 5.9. Expansion of cold chain packaging innovations to support global distribution of temperature-sensitive vaccines
  • 5.10. Increasing integration of serialization and track-and-trace technology to combat counterfeit pharmaceuticals

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Pharmaceutical Packaging Market, by Material

  • 8.1. Aluminum Foil
  • 8.2. Glass
  • 8.3. Paper
  • 8.4. Plastics & Polymers
    • 8.4.1. Polyethylene (PE)
    • 8.4.2. Polyethylene terephthalate (PET)
    • 8.4.3. Polypropylene (PP)
    • 8.4.4. Polystyrene (PS)
    • 8.4.5. Polyvinyl Chloride (PVC)

9. Pharmaceutical Packaging Market, by Product Type

  • 9.1. Ampoules
  • 9.2. Blister Packs
  • 9.3. Bottles
  • 9.4. Caps & Closures
  • 9.5. Cartridges
  • 9.6. Labels & Accessories
  • 9.7. Pouches
  • 9.8. Pre-Filled Inhalers
  • 9.9. Pre-Filled Syringes
  • 9.10. Vials

10. Pharmaceutical Packaging Market, by Level of Packaging

  • 10.1. Primary
  • 10.2. Secondary
  • 10.3. Tertiary

11. Pharmaceutical Packaging Market, by Drug Type

  • 11.1. Non-Sterile Drugs
  • 11.2. Sterile Drugs

12. Pharmaceutical Packaging Market, by Form

  • 12.1. Liquid
  • 12.2. Semi-solid
  • 12.3. Solid

13. Pharmaceutical Packaging Market, by End User

  • 13.1. Contract Manufacturing Organizations
  • 13.2. Pharmaceutical Manufacturing
    • 13.2.1. Branded Manufacturers
    • 13.2.2. Generic Manufacturers

14. Pharmaceutical Packaging Market, by Distribution

  • 14.1. Direct Sales
  • 14.2. Distributors & Wholesalers
  • 14.3. Online

15. Pharmaceutical Packaging Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Pharmaceutical Packaging Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Pharmaceutical Packaging Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. Competitive Landscape

  • 18.1. Market Share Analysis, 2024
  • 18.2. FPNV Positioning Matrix, 2024
  • 18.3. Competitive Analysis
    • 18.3.1. 3M Company
    • 18.3.2. Adelphi Group Ltd
    • 18.3.3. Alpla Werke Alwin Lehner GmbH & Co KG
    • 18.3.4. Amcor PLC
    • 18.3.5. AptarGroup, Inc.
    • 18.3.6. Becton, Dickinson and Company
    • 18.3.7. Berry Global, Inc.
    • 18.3.8. Catalent, Inc.
    • 18.3.9. CCL Industries Inc.
    • 18.3.10. Comar
    • 18.3.11. Constantia Flexibles GmbH
    • 18.3.12. Drug Plastics & Glass Co., Inc
    • 18.3.13. EPL Limited
    • 18.3.14. Gaplast GmbH
    • 18.3.15. Gerresheimer AG
    • 18.3.16. Huhtamaki Oyj
    • 18.3.17. KP Holding GmbH & Co.
    • 18.3.18. Lonza Group AG
    • 18.3.19. McKesson Corporation
    • 18.3.20. Mondi PLC
    • 18.3.21. Nipro Corporation
    • 18.3.22. Nolato AB
    • 18.3.23. Oliver Healthcare Packaging Company
    • 18.3.24. Origin Pharma Packaging
    • 18.3.25. PGP Glass Private Limited
    • 18.3.26. Schott AG
    • 18.3.27. Sealed Air Corporation
    • 18.3.28. SGD S.A.
    • 18.3.29. Sharp Services, LLC
    • 18.3.30. SiO2 Medical Products Inc.
    • 18.3.31. Stevanato Group
    • 18.3.32. TEKNI-PLEX, INC.
    • 18.3.33. Thermo Fisher Scientific Inc.
    • 18.3.34. URSATEC GmbH
    • 18.3.35. Vetter Pharma-Fertigung GmbH & Co. KG
    • 18.3.36. W. L. Gore & Associates Inc.
    • 18.3.37. West Pharmaceutical Services, Inc.
    • 18.3.38. Westrock Company by Smurfit Kappa Group

LIST OF FIGURES

  • FIGURE 1. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY LEVEL OF PACKAGING, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY LEVEL OF PACKAGING, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG TYPE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY FORM, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY FORM, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY DISTRIBUTION, 2024 VS 2032 (%)
  • FIGURE 15. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY DISTRIBUTION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AMERICAS PHARMACEUTICAL PACKAGING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. NORTH AMERICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. LATIN AMERICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. EUROPE PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. MIDDLE EAST PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. AFRICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. ASEAN PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. GCC PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. EUROPEAN UNION PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. BRICS PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. G7 PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. NATO PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 32. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 33. PHARMACEUTICAL PACKAGING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 34. PHARMACEUTICAL PACKAGING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. PHARMACEUTICAL PACKAGING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY ALUMINUM FOIL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY ALUMINUM FOIL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY ALUMINUM FOIL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY ALUMINUM FOIL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY ALUMINUM FOIL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY ALUMINUM FOIL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTICS & POLYMERS, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTICS & POLYMERS, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTICS & POLYMERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTICS & POLYMERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTICS & POLYMERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTICS & POLYMERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTICS & POLYMERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTICS & POLYMERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY POLYETHYLENE (PE), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY POLYETHYLENE (PE), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY POLYETHYLENE (PE), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY POLYETHYLENE (PE), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY POLYETHYLENE (PE), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY POLYETHYLENE (PE), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY POLYETHYLENE TEREPHTHALATE (PET), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY POLYETHYLENE TEREPHTHALATE (PET), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY POLYETHYLENE TEREPHTHALATE (PET), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY POLYETHYLENE TEREPHTHALATE (PET), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY POLYETHYLENE TEREPHTHALATE (PET), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY POLYETHYLENE TEREPHTHALATE (PET), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY POLYPROPYLENE (PP), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY POLYPROPYLENE (PP), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY POLYPROPYLENE (PP), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY POLYPROPYLENE (PP), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY POLYPROPYLENE (PP), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY POLYPROPYLENE (PP), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY POLYSTYRENE (PS), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY POLYSTYRENE (PS), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY POLYSTYRENE (PS), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY POLYSTYRENE (PS), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY POLYSTYRENE (PS), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY POLYSTYRENE (PS), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY POLYVINYL CHLORIDE (PVC), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY POLYVINYL CHLORIDE (PVC), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY POLYVINYL CHLORIDE (PVC), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY POLYVINYL CHLORIDE (PVC), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY POLYVINYL CHLORIDE (PVC), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY POLYVINYL CHLORIDE (PVC), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY AMPOULES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY AMPOULES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY AMPOULES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY AMPOULES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY AMPOULES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY AMPOULES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY BLISTER PACKS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY BLISTER PACKS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY BLISTER PACKS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY BLISTER PACKS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY BLISTER PACKS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY BLISTER PACKS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY BOTTLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY BOTTLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY BOTTLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY BOTTLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY BOTTLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY BOTTLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY CAPS & CLOSURES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY CAPS & CLOSURES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY CAPS & CLOSURES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY CAPS & CLOSURES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY CAPS & CLOSURES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY CAPS & CLOSURES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY CARTRIDGES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY CARTRIDGES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY CARTRIDGES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY CARTRIDGES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY CARTRIDGES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY CARTRIDGES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY LABELS & ACCESSORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY LABELS & ACCESSORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY LABELS & ACCESSORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY LABELS & ACCESSORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY LABELS & ACCESSORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY LABELS & ACCESSORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY POUCHES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY POUCHES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY POUCHES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY POUCHES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY POUCHES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY POUCHES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY PRE-FILLED INHALERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY PRE-FILLED INHALERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY PRE-FILLED INHALERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY PRE-FILLED INHALERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY PRE-FILLED INHALERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY PRE-FILLED INHALERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY PRE-FILLED SYRINGES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY PRE-FILLED SYRINGES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY PRE-FILLED SYRINGES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY PRE-FILLED SYRINGES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY PRE-FILLED SYRINGES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY PRE-FILLED SYRINGES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY VIALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY VIALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY VIALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY VIALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY VIALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY VIALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY LEVEL OF PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY LEVEL OF PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY PRIMARY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY PRIMARY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY PRIMARY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY PRIMARY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY PRIMARY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY PRIMARY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY SECONDARY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY SECONDARY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY SECONDARY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY SECONDARY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY SECONDARY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY SECONDARY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY TERTIARY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY TERTIARY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY TERTIARY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY TERTIARY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY TERTIARY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY TERTIARY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG TYPE, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY NON-STERILE DRUGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY NON-STERILE DRUGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY NON-STERILE DRUGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY NON-STERILE DRUGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY NON-STERILE DRUGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY NON-STERILE DRUGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY STERILE DRUGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY STERILE DRUGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY STERILE DRUGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY STERILE DRUGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY STERILE DRUGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY STERILE DRUGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY LIQUID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY LIQUID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY LIQUID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY LIQUID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY SEMI-SOLID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY SEMI-SOLID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY SEMI-SOLID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY SEMI-SOLID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY SEMI-SOLID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY SEMI-SOLID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY SOLID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY SOLID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY SOLID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY SOLID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY SOLID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY SOLID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY BRANDED MANUFACTURERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY BRANDED MANUFACTURERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY BRANDED MANUFACTURERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY BRANDED MANUFACTURERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY BRANDED MANUFACTURERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY BRANDED MANUFACTURERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY GENERIC MANUFACTURERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY GENERIC MANUFACTURERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY GENERIC MANUFACTURERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY GENERIC MANUFACTURERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY GENERIC MANUFACTURERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY GENERIC MANUFACTURERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY DISTRIBUTION, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY DISTRIBUTION, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY DISTRIBUTORS & WHOLESALERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY DISTRIBUTORS & WHOLESALERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY DISTRIBUTORS & WHOLESALERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY DISTRIBUTORS & WHOLESALERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY DISTRIBUTORS & WHOLESALERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY DISTRIBUTORS & WHOLESALERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY ONLINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY ONLINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY ONLINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY ONLINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 229. AMERICAS PHARMACEUTICAL PACKAGING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 230. AMERICAS PHARMACEUTICAL PACKAGING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 231. AMERICAS PHARMACEUTICAL PACKAGING MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 232. AMERICAS PHARMACEUTICAL PACKAGING MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 233. AMERICAS PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTICS & POLYMERS, 2018-2024 (USD MILLION)
  • TABLE 234. AMERICAS PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTICS & POLYMERS, 2025-2032 (USD MILLION)
  • TABLE 235. AMERICAS PHARMACEUTICAL PACKAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. AMERICAS PHARMACEUTICAL PACKAGING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 237. AMERICAS PHARMACEUTICAL PACKAGING MARKET SIZE, BY LEVEL OF PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 238. AMERICAS PHARMACEUTICAL PACKAGING MARKET SIZE, BY LEVEL OF PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 239. AMERICAS PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
  • TABLE 240. AMERICAS PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG TYPE, 2025-2032 (USD MILLION)
  • TABLE 241. AMERICAS PHARMACEUTICAL PACKAGING MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 242. AMERICAS PHARMACEUTICAL PACKAGING MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 243. AMERICAS PHARMACEUTICAL PACKAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. AMERICAS PHARMACEUTICAL PACKAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 245. AMERICAS PHARMACEUTICAL PACKAGING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2024 (USD MILLION)
  • TABLE 246. AMERICAS PHARMACEUTICAL PACKAGING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2025-2032 (USD MILLION)
  • TABLE 247. AMERICAS PHARMACEUTICAL PACKAGING MARKET SIZE, BY DISTRIBUTION, 2018-2024 (USD MILLION)
  • TABLE 248. AMERICAS PHARMACEUTICAL PACKAGING MARKET SIZE, BY DISTRIBUTION, 2025-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. NORTH AMERICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. NORTH AMERICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 252. NORTH AMERICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTICS & POLYMERS, 2018-2024 (USD MILLION)
  • TABLE 254. NORTH AMERICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTICS & POLYMERS, 2025-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. NORTH AMERICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. NORTH AMERICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY LEVEL OF PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 258. NORTH AMERICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY LEVEL OF PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 259. NORTH AMERICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
  • TABLE 260. NORTH AMERICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG TYPE, 2025-2032 (USD MILLION)
  • TABLE 261. NORTH AMERICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 262. NORTH AMERICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 263. NORTH AMERICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 264. NORTH AMERICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 265. NORTH AMERICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2024 (USD MILLION)
  • TABLE 266. NORTH AMERICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2025-2032 (USD MILLION)
  • TABLE 267. NORTH AMERICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY DISTRIBUTION, 2018-2024 (USD MILLION)
  • TABLE 268. NORTH AMERICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY DISTRIBUTION, 2025-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. LATIN AMERICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. LATIN AMERICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 272. LATIN AMERICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 273. LATIN AMERICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTICS & POLYMERS, 2018-2024 (USD MILLION)
  • TABLE 274. LATIN AMERICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTICS & POLYMERS, 2025-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 276. LATIN AMERICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 277. LATIN AMERICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY LEVEL OF PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 278. LATIN AMERICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY LEVEL OF PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 279. LATIN AMERICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. LATIN AMERICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG TYPE, 2025-2032 (USD MILLION)
  • TABLE 281. LATIN AMERICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 282. LATIN AMERICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 283. LATIN AMERICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 284. LATIN AMERICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 285. LATIN AMERICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2024 (USD MILLION)
  • TABLE 286. LATIN AMERICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2025-2032 (USD MILLION)
  • TABLE 287. LATIN AMERICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY DISTRIBUTION, 2018-2024 (USD MILLION)
  • TABLE 288. LATIN AMERICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY DISTRIBUTION, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTICS & POLYMERS, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTICS & POLYMERS, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY LEVEL OF PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY LEVEL OF PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG TYPE, 2025-2032 (USD MILLION)
  • TABLE 301. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 302. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL PACKAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 305. EURO